[1]
|
Barbari, C., et al. (2020) Immunotherapies and Combination Strategies for Immuno-Oncology. International Journal of Molecular Sciences, 21, Article 5009. https://doi.org/10.3390/ijms21145009
|
[2]
|
Herrera, F.G., et al. (2019) Ra-tional Combinations of Immunotherapy with Radiotherapy in Ovarian Cancer. The Lancet Oncology, 20, e417-e433. https://doi.org/10.1016/S1470-2045(19)30401-2
|
[3]
|
Takahashi, J. and Nagasawa, S. (2020) Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review. International Journal of Molecular Sciences, 21, Article 9324.
https://doi.org/10.3390/ijms21239324
|
[4]
|
Zietman, A.L. and Yom, S.S. (2020) Radiation Therapy and the Im-mune System: A Scientific Revolution in the Making. International Journal of Radiation Oncology, Biology, Physics, 108, 1-2.
https://doi.org/10.1016/j.ijrobp.2020.06.037
|
[5]
|
Turgeon, G.A., Andrew, W., Arun, A.A., Benjamin, S. and Shankar, S. (2019) Radiotherapy and Immunotherapy: A Synergistic Effect in Cancer Care. Medical Journal of Australia, 210, 47-53. https://doi.org/10.5694/mja2.12046
|
[6]
|
Brandmaier, A. and Formenti, S.C. (2020) The Impact of Ra-diation Therapy on Innate and Adaptive Tumor Immunity. Seminars in Radiation Oncology, 30, 139-144. https://doi.org/10.1016/j.semradonc.2019.12.005
|
[7]
|
Deng, L., et al. (2014) Irradiation and Anti-PD-L1 Treatment Synergistically Promote Antitumor Immunity in Mice. The Journal of Clinical Investigation, 124, 687-695. https://doi.org/10.1172/JCI67313
|
[8]
|
Janopaul-Naylor, J.R., Shen, Y., Qian, D.C. and Buchwald, Z.S. (2021) The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances. International Journal of Molecular Sciences, 22, Arti-cle 11061.
https://doi.org/10.3390/ijms222011061
|
[9]
|
Demaria, S. and Formenti, S.C. (2020) The Abscopal Effect 67 Years Later: From a Side Story to Center Stage. The British Journal of Radiology, 93, 20200042. https://doi.org/10.1259/bjr.20200042
|
[10]
|
Abuodeh, Y., Venkat, P. and Kim, S. (2016) Systematic Review of Case Reports on the Abscopal Effect. Current Problems in Cancer, 40, 25-37. https://doi.org/10.1016/j.currproblcancer.2015.10.001
|
[11]
|
Monjazeb, A.M., et al. (2020) Effects of Radiation on the Tumor Microenvironment. Seminars in Radiation Oncology, 30, 145-157. https://doi.org/10.1016/j.semradonc.2019.12.004
|
[12]
|
Zhang, Z., Liu, X., Chen, D. and Yu, J. (2022) Radiotherapy Combined with Immunotherapy: The Dawn of Cancer Treatment. Signal Transduction and Targeted Therapy, 7, Article No. 258.
https://doi.org/10.1038/s41392-022-01102-y
|
[13]
|
Rodríguez-Ruiz, M.E., Vanpouille-Box, C., Melero, I., Formenti, S.C. and Demaria, S. (2018) Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect. Trends in Immunology, 39, 644-655.
https://doi.org/10.1016/j.it.2018.06.001
|
[14]
|
Demaria, S., et al. (2004) Ionizing Radiation Inhibition of Distant Un-treated Tumors (Abscopal Effect) Is Immune Mediated. International Journal of Radiation Oncology∙Biology∙Physics, 58, 862-870.
https://doi.org/10.1016/j.ijrobp.2003.09.012
|
[15]
|
Citrin, D.E. (2017) Recent Developments in Radiotherapy. The New England Journal of Medicine, 377, 1065-1075.
https://doi.org/10.1056/NEJMra1608986
|
[16]
|
Procureur, A., et al. (2021) Enhance the Immune Checkpoint Inhibi-tors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments. Cancers, 13, Article 678.
https://doi.org/10.3390/cancers13040678
|
[17]
|
Jarosz-Biej, M., et al. (2019) Tumor Microenvironment as a “Game Changer” in Cancer Radiotherapy. International Journal of Molecular Sciences, 20, Article 3212. https://doi.org/10.3390/ijms20133212
|
[18]
|
Wang, N., et al. (2022) Radiation-Induced PD-L1 Expression in Tumor and Its Microenvironment Facilitates Cancer-Immune Escape: A Narrative Review. Annals of Translational Medicine, 10, 1-15,
https://doi.org/10.21037/atm-22-6049
|
[19]
|
Gallo, P.M. and Gallucci, S. (2013) The Dendritic Cell Response to Classic, Emerging and Homeostatic Danger Signals. Implications for Autoimmunity. Frontiers in Immunology, 4, Article 138.
https://doi.org/10.3389/fimmu.2013.00138
|
[20]
|
Merrick, A., et al. (2005) Immunosuppressive Effects of Radiation on Human Dendritic Cells: Reduced IL-12 Production on Activation and Impairment of Naive T-cell Priming. British Journal of Cancer, 92, 1450-1458.
https://doi.org/10.1038/sj.bjc.6602518
|
[21]
|
Wunderlich, R., Ernst, A., Rödel, F., Fietkau, R., Ott, O., Lauber, K., Frey, B. and Gaipl, U.S. (2015) Low and Moderate Doses of Ionizing Radiation up to 2 Gy Modulate Transmigration and Chemotaxis of Activated Macrophages, Provoke an Anti-Inflammatory Cytokine Milieu, but Do Not Impact upon Viability and Phagocytic Function. Clinical and Experimental Immunology, 179, 50-61. https://doi.org/10.1111/cei.12344
|
[22]
|
Matsumura, S., et al. (2008) Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells. The Journal of Immunology, 181, 3099-3107. https://doi.org/10.4049/jimmunol.181.5.3099
|
[23]
|
Gupta, A., et al. (2012) Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation. The Journal of Immunology, 189, 558-566. https://doi.org/10.4049/jimmunol.1200563
|
[24]
|
Thomas, D.A. and Massagué, J. (2005) TGF-β Directly Targets Cytotoxic T Cell Functions during Tumor Evasion of Immune Surveillance. Cancer Cell, 8, 369-380. https://doi.org/10.1016/j.ccr.2005.10.012
|
[25]
|
Lee, Y., et al. (2009) Therapeutic Effects of Ablative Radiation on Local Tumor Require CD8+ T Cells: Changing Strategies for Cancer Treatment. Blood, 114, 589-595. https://doi.org/10.1182/blood-2009-02-206870
|
[26]
|
Burnette, B.C., et al. (2011) The Efficacy of Radiotherapy Re-lies upon Induction of Type i Interferon-Dependent Innate and Adaptive Immunity. Cancer Research, 71, 2488-2496. https://doi.org/10.1158/0008-5472.CAN-10-2820
|
[27]
|
Mouw, K.W., Goldberg, M.S., Konstantinopoulos, P.A. and D’Andrea, A.D. (2017) DNA Damage and Repair Biomarkers of Immunotherapy Response. Cancer Discovery, 7, 675-693. https://doi.org/10.1158/2159-8290.CD-17-0226
|
[28]
|
Cloosen, S., Arnold, J., Thio, M., Bos, G.M.J., Kyewski, B. and Germeraad, W.T.V. (2007) Expression of Tumor-Asso- ciated Differentiation Antigens, MUC1 Gly-coforms and CEA, in Human Thymic Epithelial Cells: Implications for Self-Tolerance and Tumor Therapy. Cancer Re-search, 67, 3919-3926.
https://doi.org/10.1158/0008-5472.CAN-06-2112
|
[29]
|
Wang, Y., Shi, T., Song, X., Liu, B. and Wei, J. (2021) Gene Fusion Neoantigens: Emerging Targets for Cancer Immunotherapy. Cancer Letters, 506, 45-54. https://doi.org/10.1016/j.canlet.2021.02.023
|
[30]
|
Aleksic, M., et al. (2012) Different Affinity Windows for Virus and Cancer-Specific T-Cell Receptors: Implications for Therapeutic Strategies. European Journal of Immunology, 42, 3174-3179. https://doi.org/10.1002/eji.201242606
|
[31]
|
Tan, M.P., et al. (2015) T Cell Receptor Binding Affinity Governs the Functional Profile of Cancer-Specific CD8+ T Cells. Clinical and Experimental Immunology, 180, 255-270. https://doi.org/10.1111/cei.12570
|
[32]
|
Bhalla, N., Brooker, R. and Brada, M. (2018) Combining Immunotherapy and Radiotherapy in Lung Cancer. Journal of Thoracic Disease, 10, S1447-S1460. https://doi.org/10.21037/jtd.2018.05.107
|
[33]
|
Demaria, S. and Formenti, S.C. (2012) Role of T Lymphocytes in Tumor Response to Radiotherapy. Frontiers in Oncology, 2, Article 95. https://doi.org/10.3389/fonc.2012.00095
|
[34]
|
Boone, B.A. and Lotze, M.T. (2014) Targeting Damage-Associated Molecular Pattern Molecules (DAMPs) and DAMP Receptors in Melanoma. In: Thurin, M. and Marincola, F., Eds., Molecular Diagnostics for Melanoma, Methods in Molecular Biology, Vol. 1102, Humana Press, Totowa, 537-552.
https://doi.org/10.1007/978-1-62703-727-3_29
|
[35]
|
Vanpouille-Box, C., et al. (2017) DNA Exonuclease Trex1 Regulates Radiotherapy-Induced Tumour Immunogenicity. Nat Commun, 8, Article No. 15618. https://doi.org/10.1038/ncomms15618
|
[36]
|
Vanpouille-Box, C., Formenti,, S.C. and Demaria, S. (2017) TREX1 Dictates the Immune Fate of Irradiated Cancer Cells. Oncoimmunology, 6, e1339857. https://doi.org/10.1080/2162402X.2017.1339857
|
[37]
|
Lugade, A.A., et al. (2008) Radiation-Induced IFN-Gamma Production within the Tumor Microenvironment Influences Antitumor Immunity. The Journal of Immunology, 180, 3132-3139. https://doi.org/10.4049/jimmunol.180.5.3132
|
[38]
|
Tabi, Z., et al. (2010) Resistance of CD45RA-T Cells to Apoptosis and Functional Impairment and Activation of Tumor-Antigen Specific T Cells during Radiation Ther-apy of Prostate Cancer. The Journal of Immunology, 185, 1330- 1339. https://doi.org/10.4049/jimmunol.1000488
|
[39]
|
Ma, Y., Pitt, J.M., Li, Q. and Yang, H. (2017) The Renaissance of Anti-Neoplastic Immunity from Tumor Cell Demise. Immunological Reviews, 280, 194-206. https://doi.org/10.1111/imr.12586
|
[40]
|
Sundahl, N., et al. (2019) Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma. European Urology, 75, 707-711.
https://doi.org/10.1016/j.eururo.2019.01.009
|
[41]
|
Qin, R., et al. (2016) Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated with Ipilimumab. International Journal of Radiation Oncology, Biology, Physics, 96, 72-77.
https://doi.org/10.1016/j.ijrobp.2016.04.017
|
[42]
|
Dovedi, S.J., et al. (2014) Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade. Cancer Research, 74, 5458-5468. https://doi.org/10.1158/0008-5472.CAN-14-1258
|
[43]
|
Reynders, K., et al. (2015) The Abscopal Effect of Local Radiotherapy: Using Immunotherapy to Make a Rare Event Clinically Relevant. Cancer Treatment Reviews, 41, 503-510. https://doi.org/10.1016/j.ctrv.2015.03.011
|
[44]
|
Pinedo, H.M., et al. (2003) Extended Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Combined with GM-CSF: Effect on Tumour-Draining Lymph Node Dendritic Cells. European Journal of Cancer, 39, 1061-1067.
https://doi.org/10.1016/S0959-8049(03)00131-X
|
[45]
|
Siva, S., MacManus, M.P., Martin, R.F. and Martin, O.A. (2015) Abscopal Effects of Radiation Therapy: A Clinical Review for the Radiobiologist. Cancer Letters, 356, 82-90. https://doi.org/10.1016/j.canlet.2013.09.018
|
[46]
|
Dewan, M.Z., et al. (2009) Fractionated but Not Single-Dose Ra-diotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody. Clinical Can-cer Research, 15, 5379-5388.
https://doi.org/10.1158/1078-0432.CCR-09-0265
|
[47]
|
Wang, K., et al. (2023) Intensity-Modulated Radiotherapy Combined with Systemic Atezolizumab and Bevacizumab in Treatment of Hepatocellular Carcinoma with Extrahepatic Portal Vein Tumor Thrombus: A Preliminary Multicenter Single-Arm Prospective Study. Frontiers in Immunology, 14, Article 1107542.
https://doi.org/10.3389/fimmu.2023.1107542
|
[48]
|
Wang, W., Huang, C., Wu, S., Liu, Z., Liu, L. Li, L. and Li, S. (2020) Abscopal Effect Induced by Modulated Radiation Therapy and Pembrolizumab in a Patient with Pancreatic Meta-static Lung Squamous Cell Carcinoma. Thoracic Cancer, 11, 2014-2017. https://doi.org/10.1111/1759-7714.13427
|
[49]
|
Belgioia, L., et al. (2019) Safety and Efficacy of Combined Radio-therapy, Immunotherapy and Targeted Agents in Elderly Patients: A Literature Review. Critical Reviews in Oncolo-gy/Hematolog, 133, 163-170.
https://doi.org/10.1016/j.critrevonc.2018.11.009
|
[50]
|
Kroeze, S.G., et al. (2017) Toxicity of Concurrent Stereotactic Radiotherapy and Targeted Therapy or Immunotherapy: A Systematic Review. Cancer Treatment Reviews, 53, 25-37. https://doi.org/10.1016/j.ctrv.2016.11.013
|
[51]
|
Grimaldi, A.M., et al. (2014) Abscopal Effects of Radiotherapy on Advanced Melanoma Patients Who Progressed after Ipilimumab Immunotherapy. Oncoimmunology, 3, e28780. https://doi.org/10.4161/onci.28780
|
[52]
|
Woo, S.R., et al. (2012) Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-Cell Function to Promote Tumoral Immune Escape. Cancer Research, 72, 917-927. https://doi.org/10.1158/0008-5472.CAN-11-1620
|
[53]
|
Ruffo, E., Wu, R.C., Bruno, T.C., Workman, C.J. and Vignali, D.A.A. (2019) Lymphocyte-Activation Gene 3 (LAG3): The Next Immune Checkpoint Receptor. Seminars in Immunology, 42, Article ID: 101305.
https://doi.org/10.1016/j.smim.2019.101305
|
[54]
|
Strigari, L., et al. (2014) Abscopal Effect of Radiation Therapy: Interplay between Radiation Dose and p53 Status. International Journal of Radiation Biology, 90, 248-255. https://doi.org/10.3109/09553002.2014.874608
|
[55]
|
Camphausen, K., et al. (2003) Radiation Abscopal Antitumor Effect Is Mediated through p53. Cancer Research, 63, 1990-1993.
|